Sosei Heptares’ COVID-19 programme advances promising molecules
R&D programme is focused on developing small molecules against SARS-CoV-2 virus
Read More
Tag: Sosei Heptares
Sosei Heptares scores $5m milestone payment from Pfizer
First subject dosed with new drug candidate from strategic collaboration
Read More
Sosei Heptares, Takeda embark on strategic R&D partnership
The collaboration will combine Sosei’s structure-based drug design capabilities with Takeda’s discovery, development and therapeutic area expertise.
Read More
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
